Event Type
Disclosure
Mandatory
Variant
8-K
and Item 9.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exc
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release of Vaxcyte, Inc., dated Febr uary 24 , 2026 104 Cover Page Interac